CD274 and cancer: Considering that type I IFN plays a significant role in malignant growth [41], and that cGAS potentiates insusceptible designated spot barricade in programmed cell death ligand-1 (PDL-1) treatment [42], autophagy (or LAP) with type I IFN reactions associated with STING-TBK1 represent a potential target for cancer treatment.